A comparison of different machine-learning techniques for the selection of a panel of metabolites allowing early detection of brain tumors
暂无分享,去创建一个
M. Kretowski | K. Kamiński | M. Moniuszko | A. Krętowski | M. Ciborowski | Z. Mariak | J. Reszeć | P. Mojsak | Adrian Godlewski | M. Czajkowski | M. Kondraciuk | T. Pieńkowski | T. Lyson | W. Gosk | Wioleta Gosk
[1] D. Louis,et al. The 2021 World Health Organization Classification of Tumors of the Central Nervous System: What Neuroradiologists Need to Know , 2022, American Journal of Neuroradiology.
[2] E. Li,et al. Guide to Metabolomics Analysis: A Bioinformatics Workflow , 2022, Metabolites.
[3] M. Ciborowski,et al. Proteomics and metabolomics approach in adult and pediatric glioma diagnostics. , 2022, Biochimica et biophysica acta. Reviews on cancer.
[4] Zaved Siddiqui,et al. A non-invasive method for concurrent detection of early-stage women-specific cancers , 2022, Scientific Reports.
[5] Fan Yang,et al. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer , 2022, Cell Research.
[6] A. Feuchtinger,et al. The synergism of spatial metabolomics and morphometry improves machine learning‐based renal tumour subtype classification , 2022, Clinical and translational medicine.
[7] M. Stampfer,et al. A prospective study of pre-diagnostic circulating tryptophan and kynurenine, and the kynurenine/tryptophan ratio and risk of glioma. , 2021, Cancer Epidemiology.
[8] B. Bojko,et al. Metabolomic Phenotyping of Gliomas: What Can We Get with Simplified Protocol for Intact Tissue Analysis? , 2022, Cancers.
[9] Yuanting Zheng,et al. Correction: Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway , 2021, Signal Transduction and Targeted Therapy.
[10] M. Kretowski,et al. Integration of solutions and services for multi-omics data analysis towards personalized medicine , 2021, Biocybernetics and Biomedical Engineering.
[11] T. Xiong,et al. Trends in Intracranial Glioma Incidence and Mortality in the United States, 1975-2018 , 2021, Frontiers in Oncology.
[12] H. Azzazy,et al. Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion , 2021, Lipids in Health and Disease.
[13] A. Gyenesei,et al. Gut Microbiome in Chronic Coronary Syndrome Patients , 2021, Journal of clinical medicine.
[14] R. Bachoo,et al. Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas. , 2021, Neuro-oncology.
[15] Leo L. Cheng,et al. Dysregulated Alanine as a Potential Predictive Marker of Glioma—An Insight from Untargeted HRMAS-NMR and Machine Learning Data , 2021, Metabolites.
[16] W. Mao,et al. Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma , 2021, Diagnostics.
[17] G. Reifenberger,et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. , 2021, Neuro-oncology.
[18] Marek Kretowski,et al. Accelerated evolutionary induction of heterogeneous decision trees for gene expression-based classification , 2021, GECCO.
[19] David L. Roberts,et al. Machine Learning-Enabled Renal Cell Carcinoma Status Prediction Using Multiplatform Urine-Based Metabolomics. , 2021, Journal of proteome research.
[20] Daniel M. Rotroff,et al. Salivary metabolites are promising non‐invasive biomarkers of hepatocellular carcinoma and chronic liver disease , 2021, Liver cancer international.
[21] R. Gottlieb,et al. Elevated Asparagine Biosynthesis Drives Brain Tumor Stem Cell Metabolic Plasticity and Resistance to Oxidative Stress , 2021, Molecular Cancer Research.
[22] G. de Castro,et al. Serum Creatinine as a Potential Biomarker of Skeletal Muscle Atrophy in Non-small Cell Lung Cancer Patients , 2021, Frontiers in Physiology.
[23] Zhongqiu Liu,et al. GC-MS-based metabolomics reveals new biomarkers to assist the differentiation of prostate cancer and benign prostatic hyperplasia. , 2021, Clinica chimica acta; international journal of clinical chemistry.
[24] Xiao-mei Zhang,et al. Distinguishing Rectal Cancer from Colon Cancer Based on the Support Vector Machine Method and RNA-sequencing Data , 2021, Current Medical Science.
[25] Xiaojian Zhang,et al. Integrative Analysis of Metabolomic and Transcriptomic Data Reveals Metabolic Alterations in Glioma Patients. , 2021, Journal of proteome research.
[26] T. Cloughesy,et al. Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug , 2021, bioRxiv.
[27] E. V. Gaisler,et al. Correlation of Metabolic Profiles of Plasma and Cerebrospinal Fluid of High-Grade Glioma Patients , 2021, Metabolites.
[28] W. Papierz,et al. Plasma amino acids indicate glioblastoma with ATRX loss , 2021, Amino Acids.
[29] Guowang Xu,et al. Metabolic Alterations Related to Glioma Grading Based on Metabolomics and Lipidomics Analyses , 2020, Metabolites.
[30] Hu-dan Pan,et al. Early lung cancer diagnostic biomarker discovery by machine learning methods , 2020, Translational oncology.
[31] M. Loda,et al. Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum , 2020, Molecular Cancer Research.
[32] Eden L. Romm,et al. Finding distinctions between oral cancer and periodontitis using saliva metabolites and machine learning. , 2020, Oral diseases.
[33] Yunwen Tao,et al. Machine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma , 2020, Nature Communications.
[34] G. Milano,et al. Comparison of unsupervised machine-learning methods to identify metabolomic signatures in patients with localized breast cancer , 2020, Computational and structural biotechnology journal.
[35] A. J. Vanisree,et al. METABOLIC VARIATIONS AMONG LOW GRADE AND HIGH GRADE GLIOMAS - PROFILING BY 1H NMR SPECTROSCOPY. , 2020, Journal of proteome research.
[36] Yuanting Zheng,et al. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway , 2020, Signal Transduction and Targeted Therapy.
[37] Nicola Zamboni,et al. Targeting glioma-initiating cells via the tyrosine metabolic pathway. , 2020, Journal of neurosurgery.
[38] A. Mangoni,et al. Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer , 2020, Frontiers in Oncology.
[39] I. Namer,et al. Metabolomic profile of aggressive meningiomas by using high-resolution magic angle spinning nuclear magnetic resonance. , 2020, Journal of proteome research.
[40] S. Pitson,et al. Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma , 2020, Cancers.
[41] G. Pavesi,et al. A metabolomic data fusion approach to support gliomas grading , 2019, NMR in biomedicine.
[42] Kevin M. Mendez,et al. A comparative evaluation of the generalised predictive ability of eight machine learning algorithms across ten clinical metabolomics data sets for binary classification , 2019, Metabolomics.
[43] Mei-Ling Cheng,et al. Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy , 2019, Metabolomics.
[44] H. Baek,et al. Metabolic profiling of human gliomas assessed with NMR , 2019, Journal of Clinical Neuroscience.
[45] P. Račay,et al. Metabolomic profiling of blood plasma in patients with primary brain tumours: Basal plasma metabolites correlated with tumour grade and plasma biomarker analysis predicts feasibility of the successful statistical discrimination from healthy subjects – a preliminary study , 2019, IUBMB life.
[46] M. R. Melo-Júnior,et al. Osteopenia-osteoporosis discrimination in postmenopausal women by 1H NMR-based metabonomics , 2019, PloS one.
[47] B. Lim,et al. Methionine is a metabolic dependency of tumor-initiating cells , 2019, Nature Medicine.
[48] Xin Lu,et al. Integrated Metabolomics and Lipidomics Analyses Reveal Metabolic Reprogramming in Human Glioma with IDH1 Mutation. , 2018, Journal of proteome research.
[49] R. Shamir,et al. Multi-omic and multi-view clustering algorithms: review and cancer benchmark , 2018, Nucleic acids research.
[50] H. Jia,et al. Glycerophosphatidylcholine PC(36:1) absence and 3′-phosphoadenylate (pAp) accumulation are hallmarks of the human glioma metabolome , 2018, Scientific Reports.
[51] C. James,et al. An overview of meningiomas. , 2018, Future oncology.
[52] R. Shamir,et al. Multi-omic and multi-view clustering algorithms: review and cancer benchmark , 2018, bioRxiv.
[53] Fadhl M Alakwaa,et al. Deep Learning Accurately Predicts Estrogen Receptor Status in Breast Cancer Metabolomics Data , 2017, bioRxiv.
[54] A. Brenner,et al. Metabolomic signature of brain cancer , 2017, Molecular carcinogenesis.
[55] A. Colquhoun. Cell biology-metabolic crosstalk in glioma. , 2017, The international journal of biochemistry & cell biology.
[56] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[57] Xifeng Wu,et al. Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes , 2016, Oncotarget.
[58] N. S. Yarla,et al. Phospholipase A2: A Potential Therapeutic Target in Inflammation and Cancer (In silico, In vitro, In vivo and Clinical Approach) , 2015 .
[59] Alex Alves Freitas,et al. Evolutionary Design of Decision-Tree Algorithms Tailored to Microarray Gene Expression Data Sets , 2014, IEEE Transactions on Evolutionary Computation.
[60] Vijay Kotu,et al. Predictive Analytics and Data Mining: Concepts and Practice with RapidMiner , 2014 .
[61] A. Chinnaiyan,et al. Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target. , 2012, The international journal of biochemistry & cell biology.
[62] Peter Canoll,et al. The cellular origin for malignant glioma and prospects for clinical advancements , 2012, Expert review of molecular diagnostics.
[63] D. Monleón,et al. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities. , 2010, Cancer research.
[64] Joseph Wiemels,et al. Epidemiology and etiology of meningioma , 2010, Journal of Neuro-Oncology.
[65] F. Howe,et al. Taurine: a potential marker of apoptosis in gliomas , 2009, British Journal of Cancer.
[66] David Bensimon,et al. Some nonlinear challenges in biology , 2008 .
[67] F. Fazzino,et al. Taurine as a Micronutrient in Development and Regeneration of the Central Nervous System , 2001, Nutritional neuroscience.
[68] M. Wyss,et al. Creatine and creatinine metabolism. , 2000, Physiological reviews.
[69] Y. Kinoshita,et al. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy , 1997, NMR in biomedicine.
[70] Jack Ngarambe,et al. Recent advances in black box and white-box models for urban heat island prediction: Implications of fusing the two methods , 2022, Renewable and Sustainable Energy Reviews.
[71] A. Krętowski,et al. A review of gliomas-related proteins. Characteristics of potential biomarkers. , 2021, American journal of cancer research.
[72] K. Chou,et al. Glioma stages prediction based on machine learning algorithm combined with protein-protein interaction networks. , 2019, Genomics.
[73] [World Health Organization classification of tumours of the central nervous system: a summary]. , 2016, Zhonghua bing li xue za zhi = Chinese journal of pathology.
[74] M. Walid. Prognostic factors for long-term survival after glioblastoma. , 2008, The Permanente journal.
[75] J. Sneep,et al. With a summary , 1945 .